DOI: http://dx.doi.org/10.18203/2349-2902.isj20195114

A study of prognostic factors in cutaneous malignant melanoma

M. N. Sasikumar, Annie Sandhya Kurian

Abstract


Background: Melanocytes are cells of neural crest origin that migrate principally to basement membrane of skin at dermo-epidermal junction. These cells when exposed to carcinogens result in malignant melanoma. Melanoma accounts for only 4% to 5% of all skin cancers but causes majority of deaths from skin cancers. Several factors affect its prognosis. Most reports agree that tumour thickness is the most important factor, but several others also interact.

Methods: From the department of Medical College, Kottayam the cancer of patient who had histopathologically proven malignant melanoma during 2008-2012 were obtained from this HPR, details of the lesion such as Breslows thickness, level of invasion, presence of ulceration, mitoses, lymphocytic infiltration, tumor vascularity etc. were recorded. The case records of the some patients were then obtained from the record library, from which the clinical details of the lesions and follow up were recorded. These patients were followed till 2013. The significance and each of these factors were these analysed.

Results: There were a total of 64 cases with equal gender distribution. The incidence reflected the global trend of increasing number of cases. The factors which affect prognosis included nodal status, thickness, level of invasion, ulceration, mitoses, lymphocyte infiltration, vascularity and lymphovascular emboli. A striking finding was most of the patients presented at an advanced stage, unlike the West.

Conclusions: Malignant melanoma is a deadly disease especially when diagnosed late. Many factors in addition to thickness were found to have prognostic significance.


Keywords


Malignant melanoma, Prognostic factors, Thickness, Nodal status, Lymphocyte infiltration, Lymphovascular emboli

Full Text:

PDF

References


Siegel R Naishedhan D, Jemal A Cancer statistics 2012. Cancer J Clin. 2012;62:10-29.

Breslow A. Thickness cross sectional area and depth of invasion in the prognosis of cutaneous melanoma. Ann of Surg. 1970.

Balch CM, Soong SJ, Gershenwald JE. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Cli Oncol. 2001;19:3622.

Change AE, Karnell LH, Menck HR. The National Cancer Data Base Report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664.

Paek SC, Griffith KA, Johnson. The impact of factors beyond Breslow depth on prediciting sentinel lymph node positivity in melanoma. Cancer. 2007;109:100.

Slingluff CLJ, Vollmer RT, Reintgen DS,. Lethal thin malignant melanoma. Identifying patients at risk. Annu Surg. 1988;208:150.

DeVita, Vincent T, Loerence, Theodore S, Rosenberg, Steven A, et al. Devita, Hellman and Rosenberg’s Cancer: Principles and Practies of Oncology. In: DeVita Jr, Vincent T, Lawrence TS, Rosenberg SA, eds. 8th edition. Wolters Kluwer; 2008: 1897-1898.

Slingluff CLJ, Vollmer R, Seigler HF. Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol. 1990;45:91-8.

Slingluff CLJ, Seigler HF. Anorectal melanoma: clinical charcteristics and the role of abdominoperineal resection. Ann Plast Surg. 1992;28:85.

Gillgren P. Dept of Oncology and pathology, karolinskaInstitute, Stockholm, Body site of cutaneous malignant melanoma primary tumor location in relation to phenotypic and prognostic factors. Karolinska University Press; 2002.

Yeh JJ, Shia J, Hwu WJ. The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg. 2006;244:1012.

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, et al. AJCC Cancer Staging Manual, Seventh Edition. Melanoma of the Skin. 2010: 325.

Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Breslow RSB. Thickness and Clark Level in Melanoma. Support for Including Level in Pathology Reports and in America Joint Committee on Cancer Staging. Cancer. 2000;88(3):589-95

Gershenwald JE, Soong SJ, Thompson JF. Prognostic factors and natural history in cutaneous melanoma. In: Balch CM, Sober AJ, eds. Cutaneous melanoma, 4 th ed. St. Louis, MO: Quality Medical Publishing. 2003;25:1948.

Homsi J, Kashani-Sabet M, Messina JL, Daud A. Cutaneous Melanoma: Prognostic Factors. Cancer Control. 2005;12(4):223-9.

Clark WH, From L, Bernardino EA. The hisstogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29:705.